— Moving Forward with KFBIO

As the year draws to a close,
we say goodbye to 2025 with gratitude—and welcome 2026 with confidence and anticipation.

The past year has been a meaningful chapter for KFBIO.
In 2025, we continued to advance digital pathology with focus and determination—bringing technology closer to real clinical practice, expanding from local innovation to global collaboration, and supporting laboratories and pathologists with solutions that are practical, reliable, and future-ready.

Throughout the year, we stayed committed to:

• Technology at the core — enhancing scanner performance, system stability, workflow efficiency, and data security.
• Real-world application — enabling digital pathology across clinical diagnosis, education, research, and regional collaboration.
• A global perspective — delivering solutions developed in China to partners and institutions around the world.

Every successful deployment, every system go-live, and every conversation with partners across borders has been built on trust, professionalism, and shared vision. These moments define what 2025 has meant to us.

As we step into 2026, we move forward with clarity and purpose:
to deliver more mature and integrated solutions,
to collaborate more openly across regions and disciplines,
and to continue investing patiently in the long-term value of digital pathology.

Goodbye 2025—thank you for every journey shared.
Hello 2026—the future is already in motion.

With the New Year approaching,
KFBIO extends our warmest wishes to our global customers, partners, and colleagues:

May the new year bring progress, resilience, and new possibilities for all.